Handelsbanken Fonder’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
IA
CAMG
YIH
CPC
SO
CG
FHA
PFSRSONJ
Handelsbanken Fonder's AUPH Position: Q2 2026 in Review
Handelsbanken Fonder increased its Aurinia Pharmaceuticals (AUPH) stake by 8.9% in Q2 2026, buying an estimated $67.1K and bringing the position to 51,400 shares worth $872K. The position accounts for ﹤0.01% of the portfolio, ranked #1196.
Handelsbanken Fonder first reported a position in AUPH in Q4 2021 and has held it in 19 quarters since. 64 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.
- Handelsbanken Fonder held 51,400 shares of Aurinia Pharmaceuticals worth $872K as of Q2 2026.
- Handelsbanken Fonder bought 4,200 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $67.1K.
- Aurinia Pharmaceuticals made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1196 holding.
- Handelsbanken Fonder first reported a position in Aurinia Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
- 64 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.
Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.